Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Panchsheel OrganicsBOM:531726 +1.61%72 EBITDA Margin % is 11.86% as of Mar. 2026, which is 32% below its 10-year median of 17.53. GuruFocus rates BOM:531726 with a GF Score™ of 72/100 and a GF Value™ of ₹170.13 (Modestly Undervalued). The stock has 5 warning signs investors should review. Among 960 Drug Manufacturers companies, Panchsheel Organics ranks better than 58.96% on this metric.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Panchsheel Organics EBITDA Margin % Related Terms
Panchsheel Organics EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Panchsheel Organics's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Panchsheel Organics's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panchsheel Organics EBITDA Margin % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panchsheel Organics's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Panchsheel Organics's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Panchsheel Organics (BOM:531726) has a EBITDA Margin % of 11.86% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Panchsheel Organics and its competitors. This is 32% below median its historical median of 17.53. Over the past decade, Panchsheel Organics' EBITDA Margin % has ranged from 14.61 to 20.28. According to the industry distribution chart, Panchsheel Organics ranks #394 out of 960 companies in the Drug Manufacturers industry, placing it in the top 41%.
Is Panchsheel Organics' EBITDA Margin % too high?
Panchsheel Organics' current EBITDA Margin % of 11.86% is 32% below median its 10-year median of 17.53. Over the past 10 years, this metric has ranged from a low of 14.61 to a high of 20.28. The Drug Manufacturers industry median EBITDA Margin % is 12.45. Panchsheel Organics' value of 11.86% is 4.7% below this industry median. Based on the distribution chart, Panchsheel Organics ranks #394 out of 960 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, Panchsheel Organics has a GF Score™ of 72/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Panchsheel Organics' EBITDA Margin % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Panchsheel Organics ranks #394 out of 960 companies for EBITDA Margin %. This puts Panchsheel Organics in the upper half of its industry. The industry median EBITDA Margin % is 12.45. Panchsheel Organics' value of 11.86% is 4.7% below this benchmark. Historically, Panchsheel Organics' own EBITDA Margin % has ranged from 14.61 to 20.28 over the past decade. While the company's 10-year median is 17.53 vs. the industry median of 12.45, Panchsheel Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.45, based on 960 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Panchsheel Organics's current EBITDA Margin % of 11.86% is 4.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Panchsheel Organics and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.45 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panchsheel Organics's current EBITDA Margin % is 11.86%, which is 32% below median its own 10-year median of 17.53. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panchsheel Organics stock overvalued right now?
Based on GuruFocus' analysis, Panchsheel Organics (BOM:531726) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹170.13, compared to a current price of ₹120.00 — trading 29.5% below its estimated fair value. The current EBITDA Margin % is 11.86%, which is 32% below median its 10-year median of 17.53 and 4.7% below the Drug Manufacturers industry median of 12.45. Panchsheel Organics' overall GF Score™ is 72/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Panchsheel Organics (BOM:531726), the current EBITDA Margin % is 11.86% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Panchsheel Organics (BOM:531726) Overvalued in 2026?
Based on GuruFocus' analysis, Panchsheel Organics stock appears to be undervalued.
The current stock price of ₹120.00 is trading 29.5% below its estimated GF Value™ of ₹170.13.
GuruFocus considers Panchsheel Organics to be Modestly Undervalued.
Key valuation signals for BOM:531726:
EBITDA Margin %: 11.86% (32% below median its 10-year median of 17.53)
GF Value™: ₹170.13 vs. price of ₹120.00 (29.5% below fair value)
Industry Position: 4.7% below the Drug Manufacturers median (#394 of 960)
No single metric tells the full story. See the BOM:531726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressProf. N. S. Phadke Marg, 137,138 Hubtown Solaris, 1st Floor, Opposite Teli Gali, Near Andheri East West Flyover, Andheri (East), Mumbai, MH, IND, 400 069
Panchsheel Organics Ltd is an India based pharmaceutical company. It is engaged in the manufacturing and exporting of Active Pharma Ingredients (APIs), intermediates, and finished formulations. The company's product categories include API and intermediaries, Steroids and Hormones, Veterinary Products, OTC Products, Oncology Products, Neutraceutical Products, and Excipients.
72GF Score
Get the complete analysis for BOM:531726
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531726 has been successfully added to your 
